Heartbeam Inc

Heartbeam Inc maintains a debt-free capital structure with a debt-to-equity ratio of 0.0, supported by cash and equivalents of $4.38 million against total liabilities of $3.24 million. The company’s total equity stands at $2.60 million, while total assets amount to $5.84 million. Despite the absence of debt, the firm faces liquidity pressure, indicated by a low liquidity risk assessment and negative operating cash flow of -$13.99 million. The market capitalization is $19.39 million, with a price-to-book ratio of 7.45, suggesting the market values the company significantly above its tangible book value.

Profitability metrics reflect early-stage or turnaround challenges, with a return on equity of -8.07% and a return on assets of -3.60%. The company reported an operating income of -$21.14 million and a net income of -$21.02 million, indicating significant operational losses. Without cohort median data for direct comparison, these negative returns highlight the company’s current inability to generate profits from its asset base or equity capital. The negative EV/EBITDA of -0.71 further underscores the lack of positive earnings before interest, taxes, depreciation, and amortization.

Segment and geographic revenue data are not provided in the available input, preventing a detailed analysis of revenue concentration or regional exposure. The absence of this information limits the ability to assess diversification risks or specific market dependencies within the Health Care Equipment & Supplies sector.

Historical period data for revenue and net income trends are not included in the input, so a growth trajectory analysis cannot be constructed. The current financial snapshot shows a single period of significant losses, but without multi-year or quarterly historical data, the directionality of these losses—whether improving or deteriorating—remains unquantified.

Risk assessment indicates low liquidity and low dilution risk, with no immediate filing-based flags detected for liquidity or dilution. The company has 26.96 million basic and diluted shares outstanding, with no difference between the two, suggesting no current dilutive securities are impacting the share count. The low dilution risk is consistent with the absence of recent issuance or ATM/shelf disclosure events in the provided data.

Recent observations include a sector contamination re-analysis via the sector classification-direct path, audited on 2026-07-13, which triggered a sector fix batch for BEAT.O. Analyst estimates show a mean price target of $3.83 and a median of $4.00, with a high of $5.00 and a low of $2.50. The mean recommendation is 2.00, driven by three buy ratings and no strong buys or holds, indicating cautious optimism from analysts despite the current financial losses.

Heartbeam Inc (BEAT.O) has undergone a comprehensive revision of its internal analytical framework, with significant updates to its business summary, key takeaways, and overall conclusion. These modifications, sourced from the ha_light_thesis, represent a structural overhaul of the company's narrative profile rather than a reaction to external market events. The changes indicate a recalibration of how the company's operations and strategic outlook are interpreted within the current analytical model. The revision process involved a substantial shift in the company's key takeaways, with seven new points added and seven removed, alongside a near-total rewrite of the narrative and conclusion sections. This level of modification suggests that previous assumptions or data inputs have been superseded by a new understanding of Heartbeam's business dynamics. The similarity scores for the narrative and conclusion were notably low, underscoring the depth of the change in the analytical perspective. Despite these internal analytical shifts, there is no evidence of material change in the company's fundamental operations or market position relative to prior analysis. The system explicitly notes that while the schema fields were updated, the core material status remains unchanged. This distinction is crucial for investors, as it separates the evolution of the analytical lens from any actual operational or financial developments at the company. Heartbeam Inc continues to operate with a lean leadership structure of two officers and maintains a shareholder base of nine top holders. The company currently lacks analyst coverage and index membership, which may contribute to the reliance on internal analytical updates for insight. With no recent dispatches or external signals recorded in the cross-source data, the recent revisions appear to be a proactive refinement of the company's profile rather than a response to immediate market catalysts.

Operating income +14,3% YoY; Net income +14,3% YoY.

• ▍Operating income +14,3% YoY
• ▍Net income +14,3% YoY
• ▍Free cash flow +10,1% YoY

Operating income −7,4% YoY; Net income −8,1% YoY.

• ▍Operating income −7,4% YoY
• ▍Net income −8,1% YoY
• ▍Free cash flow −16,4% YoY

Operating income −4,4% YoY; Net income −5,5% YoY.

• ▍Operating income −4,4% YoY
• ▍Net income −5,5% YoY

Operating income +1,0% YoY; Net income −0,4% YoY.

• ▍Operating income +1,0% YoY
• ▍Net income −0,4% YoY

Operating income -$5.5M.

• ▍Operating income -$5.5M

Operating income -$4.9M.

• ▍Operating income -$4.9M

Operating income -$5.1M.

• ▍Operating income -$5.1M

Operating income -$5.1M.

• ▍Operating income -$5.1M

Operating income −6,3% YoY; Net income −8,1% YoY.

• ▍Operating income −6,3% YoY
• ▍Net income −8,1% YoY
• ▍Free cash flow −9,8% YoY

Operating income −29,9% YoY; Net income −32,9% YoY.

• ▍Operating income −29,9% YoY
• ▍Net income −32,9% YoY

Operating income −17,5% YoY; Net income −12,9% YoY.

• ▍Operating income −17,5% YoY
• ▍Net income −12,9% YoY

Operating income −470,3% YoY; Net income −192,7% YoY.

• ▍Operating income −470,3% YoY
• ▍Net income −192,7% YoY
• ▍Free cash flow −192,7% YoY